期刊文献+

抗肿瘤药物吉非替尼的合成工艺研究 被引量:1

Study on synthesis technology of antitumor agent gefitinib
下载PDF
导出
摘要 本合成工艺以价廉、易得的4,5-二甲氧基-2-硝基苯甲酸为起始原料,经脱甲基、酯化、侧链烷基化、还原、环合、氯代、氨代反应合成了吉非替尼。整个合成路线共七步,总收率达到50%以上,纯度可达99.8%,具有操作简单、收率高、环境污染小等优点,有良好的工业化前景。 Using the inexpensive and readily available 4,5-dimethoxy-2-nitrobenzoic acid as the starting material,gefitinib was syn-thesized through demethylation, esterification, side-chain alkylation, reduction, cyclization, chlorination and ammoniation reaction. This route included seven steps,the total yield was more than 50%. The purity of product was 99. 8%. The route could reduce envi-ronmental pollution, simplify conventional processes, and had high yield. It was suitable for industrial production.
出处 《化学研究与应用》 CSCD 北大核心 2017年第9期1398-1401,共4页 Chemical Research and Application
基金 重庆市教委科技项目(KJ1504403)资助
关键词 吉非替尼 抗肿瘤药 新合成线路 gefitinib antitumor drug new synthesis technology
  • 相关文献

参考文献3

二级参考文献29

  • 1袁立,郝金恒,张勇,王玉亚,王晖,陈皎月,宫平.4-(3-氯-4-氟苯胺基)-7-甲氧基-6-[3-(4-吗啉基)丙氧基]喹唑啉的合成[J].中国药物化学杂志,2005,15(1):39-41. 被引量:8
  • 2张华,赵金浩,王晖.4-(3-氯-4-氟苯基氨基)-7-甲氧基-6-[3-(4-吗啉基)-丙氧基]喹啉的合成法[P].CN200810122242.2,2009-4-8. 被引量:2
  • 3GIUSEPPE G,HERBST R S,MANEGOLD C,et al.Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer:a phase Ⅲ trial-INTACT1[J].J Clin Oncol,2004,22(5):777-784. 被引量:1
  • 4HERBST R S,GIACCONE G,SCHILLER J H,et al.Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer a phase Ⅲ trial-INTACT2[J].J Clin Oncol,2004,2(5):785-794. 被引量:1
  • 5CAPPUZZO F,ARDIZZONI A,AOTO-PARRA H,et al.Epidermal growth factor receptor targeted therapy by ZD1839(Iressa) in patients with brain metastases from non-small cell lung cancer(NSCLC)[J].Lung Cancer,2003,41 (2):227-231. 被引量:1
  • 6LIUYN TIANQ SHEDY etal.Epidemal growth factor receptor antagonist in Non—Small—Cell Lung Cancer—questions and hopes coexist[J].中华医学信息导报,2005,20(3):1-1. 被引量:1
  • 7LORI MURRAY.Physicians' Desk Reference[M].59th.ed.Montvale:Thomson PDR,2005:658. 被引量:1
  • 8CHAN K C,KNOX W F,GEE J M,et al.Effect of epidermal growth factor receptor tyrosine kinase inhibition on epithelial proliferation in normal and premalignant breast[J].Cancer Res,2002,62(1):122-128. 被引量:1
  • 9ALBANELL J,ROJO F,BASELGA J.Pharmacodynamic studies with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839[J].Semin Oncol,2001,5(Suppl 16):56-66. 被引量:1
  • 10BASELGA J,AVERBUCH S D.ZD1839 (‘Ir essa’) as an anticancer agent[J].Drugs,2000,60(Suppl 1):33-40. 被引量:1

共引文献20

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部